The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic is a research paper published in Journal of the American Academy of Dermatology (2020). On theSindex it has a DataRank of 0. It has been cited 50 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30-AR0-69589-03
NIAMS NIH HHS
Grant: P30 AR069589
National Institutes of Health
Grant: 5P30AR069589-03
Penn Resource-based Center to Support and Translate Skin DiseasesResearch
Janssen
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Ortho Dermatologics
Pfizer
Celgene
Sanofi
Bristol-Myers Squibb
Eli Lilly and Company
AbbVie
Novartis Corp
Pfizer Inc
FWCI
3.30
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals